Li-li Fu

发表

Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats.

Xuefei Shen, B. Dai, Yawei Liu, 2010, Clinical science.

Design , synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives 1

Jian Li, Hong Liu, Bing Xiong, 2006 .

Scribble influences cyst formation in autosomal‐dominant polycystic kidney disease by regulating Hippo signaling pathway

C. Mei, Li-li Fu, Dechao Xu, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Kruppel-Like Factor 15 Modulates Renal Interstitial Fibrosis by ERK/MAPK and JNK/MAPK Pathways Regulation

C. Mei, Li-li Fu, Xiang Gao, 2013, Kidney and Blood Pressure Research.

Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: a study of the mechanism of action.

C. Mei, Li-li Fu, Xueqi Wang, 2018, American journal of physiology. Renal physiology.

Rosiglitazone Inhibits Transforming Growth Factor-β1 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells

B. Dai, Yawei Liu, C. Mei, 2011, PloS one.

DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling

C. Mei, Li-li Fu, Xishan Xiong, 2010, Investigational New Drugs.

Efficacy of Short-Term High-Dose Statin in Preventing Contrast-Induced Nephropathy: A Meta-Analysis of Seven Randomized Controlled Trials

B. Dai, Yawei Liu, C. Mei, 2012, PloS one.

Oxidized high‐density lipoprotein enhances inflammatory activity in rat mesangial cells

C. Mei, Li-li Fu, Xiang Gao, 2010, Diabetes/metabolism research and reviews.

VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.

Minjuan Wu, J. Xiong, Hou-qi Liu, 2011, American journal of physiology. Renal physiology.

Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.

C. Mei, Li-li Fu, F. Grosjean, 2011, Kidney international.

SNX9 Inhibits Cell Proliferation and Cyst Development in Autosomal Dominant Polycystic Kidney Disease via Activation of the Hippo-YAP Signaling Pathway

Li-li Fu, Sheng-qiang Yu, Wutao Wang, 2020, Frontiers in Cell and Developmental Biology.

Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis

Li-li Fu, C. Mei, L. Bu, 2019, Kidney and Blood Pressure Research.

Effects of polycystin‑1 N‑terminal fragment fusion protein on the proliferation and apoptosis of rat mesangial cells.

C. Mei, Li-li Fu, Ping Chen, 2014, Molecular medicine reports.

Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.

Ming Wu, C. Mei, Li-li Fu, 2018, American journal of physiology. Renal physiology.

Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

J. Privratsky, C. Mei, Li-li Fu, 2019, American journal of physiology. Renal physiology.

Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice.

Jie Zhou, C. Mei, Li-li Fu, 2018, Journal of the American Society of Nephrology : JASN.

Deletion of p18(INK4c) aggravates cisplatin-induced acute kidney injury.

Wei Chen, C. Mei, Li-li Fu, 2014, International journal of molecular medicine.

Overexpression of p18INK4C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis

C. Mei, Li-li Fu, Chunyan Liu, 2011, Pediatric Nephrology.

The Nephroprotective Effect of Tauroursodeoxycholic Acid on Ischaemia/Reperfusion‐Induced Acute Kidney Injury by Inhibiting Endoplasmic Reticulum Stress

C. Mei, Li-li Fu, Cheng-gang Xu, 2012, Basic & clinical pharmacology & toxicology.

Oxidized high-density lipoprotein impairs the function of human renal proximal tubule epithelial cells through CD36.

C. Mei, Li-li Fu, Cheng-gang Xu, 2014, International journal of molecular medicine.

In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

B. Dai, Yawei Liu, C. Mei, 2022, Frontiers in Medicine.

Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.

C. Mei, Li-li Fu, Chunyan Liu, 2013, Molecular medicine reports.

Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents

Jianhua Shen, B. Dai, C. Mei, 2010, Investigational New Drugs.

Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines

Jianhua Shen, B. Dai, C. Mei, 2009, Investigational New Drugs.

Comparison between effects of mycophenolate mofetil and rapamycin on proliferation and apoptosis of cyst-lining epithelial cells of ADPKD patients: Comparison between effects of mycophenolate mofetil and rapamycin on proliferation and apoptosis of cyst-lining epithelial cells of ADPKD patients

Li-li Fu, C. Mei, Tong Zhang, 2009 .

Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury.

C. Mei, Li-li Fu, Liang Wang, 2014, International journal of molecular medicine.

KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression

C. Mei, Li-li Fu, Yi Wang, 2017, Kidney and Blood Pressure Research.

Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease

Jie Zhou, Ming Wu, R. Wüthrich, 2017, Kidney and Blood Pressure Research.

B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest

Xiao-min Luo, C. Mei, Li-li Fu, 2010, Investigational New Drugs.

Inhibition of MiR-199a-5p Reduced Cell Proliferation in Autosomal Dominant Polycystic Kidney Disease through Targeting CDKN1C

Ming Wu, C. Mei, Li-li Fu, 2015, Medical science monitor : international medical journal of experimental and clinical research.

Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo

Hualiang Jiang, C. Mei, Li-li Fu, 2009, Investigational New Drugs.

Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.

Ming Wu, C. Mei, Li-li Fu, 2017, The British journal of nutrition.

NS398 as a potential drug for autosomal‐dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models

C. Mei, Li-li Fu, Z. Mao, 2021, Journal of cellular and molecular medicine.

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector

Li-li Fu, C. Mei, Jun Wu, 2015, Clinical science.

Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.

B. Dai, Yawei Liu, C. Mei, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway

Li-li Fu, C. Mei, C. Ye, 2012, Molecular Biology Reports.

Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells

C. Mei, Li-li Fu, Wei Zhou, 2018, Molecular and Cellular Biochemistry.